Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2011, Article ID 267508, 3 pages
http://dx.doi.org/10.1155/2011/267508
Case Report

Systemic Lupus Erythematosus Presenting as Thrombotic Thrombocytopenia Purpura: How Close Is Close Enough?

1Division of Hematology/Oncology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, 1475 NW 12th Avenue, D8-4 (Suite 3510), Miami, FL 33136, USA
2Rosalind Franklin University of Medicine and Science, 3333 Green Bay Road, North Chicago, IL 60064, USA

Received 22 January 2011; Accepted 16 March 2011

Academic Editor: Gilles Z. Lugassy

Copyright © 2011 Cesar A. Perez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. K. Kwok, J. H. Ju, C. S. Cho, H. Y. Kim, and S. H. Park, “Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: risk factors and clinical outcome: a single centre study,” Lupus, vol. 18, no. 1, pp. 16–21, 2009. View at Google Scholar · View at Scopus
  2. E. L. Amorosi and J. E. Ultman, “Thrombotic thrombocytopenic purpura: report of 16 cases and review of the literature,” Medicine, vol. 45, no. 2, pp. 139–159, 1966. View at Google Scholar
  3. B. Lämmle, J. A. Kremer Hovinga, and L. Alberio, “Thrombotic thrombocytopenic purpura,” Journal of Thrombosis and Haemostasis, vol. 3, no. 8, pp. 1663–1675, 2005. View at Publisher · View at Google Scholar · View at PubMed
  4. G. A. Rock, K. H. Shumak, N. A. Buskard et al., “Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura,” The New England Journal of Medicine, vol. 325, no. 6, pp. 393–397, 1991. View at Google Scholar
  5. M. P. Thomas and A. Wang, “Clinical problem-solving. Taken out of context,” The New England Journal of Medicine, vol. 359, pp. 2478–2482, 2008. View at Google Scholar
  6. C. E. Thompson, L. E. Damon, C. A. Ries, and C. A. Linker, “Thrombotic microangiopathies in the 1980s: clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic,” Blood, vol. 80, no. 8, pp. 1890–1895, 1992. View at Google Scholar
  7. J. N. George, “How I treat patients with thrombotic thrombocytopenic purpura: 2010,” Blood, vol. 116, no. 20, pp. 4060–4069, 2010. View at Publisher · View at Google Scholar · View at PubMed
  8. J. L. Moake, “Von willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura,” Seminars in Hematology, vol. 41, no. 1, pp. 4–14, 2004. View at Publisher · View at Google Scholar
  9. A. A. Shah, J. P. Higgins, and E. F. Chakravarty, “Thrombotic microangiopathic hemolytic anemia in a patient with SLE: diagnostic difficulties,” Nature Clinical Practice Rheumatology, vol. 3, no. 6, pp. 357–362, 2007. View at Publisher · View at Google Scholar · View at PubMed
  10. D. R. Terrell, S. K. Vesely, J. A. K. Hovinga, B. Lämmle, and J. N. George, “Different disparities of gender and race among the thrombotic thrombocytopenic purpura and hemolytic-uremic syndromes,” American Journal of Hematology, vol. 85, no. 11, pp. 844–847, 2010. View at Publisher · View at Google Scholar · View at PubMed
  11. P. Letchumanan, H. J. Ng, L. H. Lee, and J. Thumboo, “A comparison of thrombotic thrombocytopenic purpura in an inception cohort of patients with and without systemic lupus erythematosus,” Rheumatology, vol. 48, no. 4, pp. 399–403, 2009. View at Publisher · View at Google Scholar · View at PubMed
  12. C. Porta, E. Bobbio-Pallavicini, R. Centurioni et al., “Thrombotic thrombocytopenic purpura in systemic lupus erythematosus,” Journal of Rheumatology, vol. 20, no. 9, pp. 1625–1626, 1993. View at Google Scholar
  13. H. I. Brunner, M. Freedman, and E. D. Silverman, “Close relationship between systemic lupus erythematosus and thrombotic thrombocytopenic purpura in childhood,” Arthritis and Rheumatism, vol. 42, no. 11, pp. 2346–2355, 1999. View at Publisher · View at Google Scholar
  14. F. Musio, E. M. Bohen, C. M. Yuan, and P. G. Welch, “Review of thrombotic thrombocytopenic purpura in the setting of systemic lupus erythematosus,” Seminars in Arthritis and Rheumatism, vol. 28, no. 1, pp. 1–19, 1998. View at Publisher · View at Google Scholar
  15. P. Cacoub, N. Limal, D. Sène, I. Guichard, and J. C. Piette, “Rituximab for the treatment of thrombotic thrombocytopenic purpura in systemic lupus erythematosus,” Lupus, vol. 17, no. 1, pp. 69–71, 2008. View at Publisher · View at Google Scholar · View at PubMed
  16. A. Hundae, S. Peskoe, E. Grimsley, and S. Patel, “Rituximab therapy for refractory thrombotic thrombocytopenic purpura and autoimmune-mediated thrombocytopenia in systemic lupus erythematosus,” Southern Medical Journal, vol. 101, no. 9, pp. 943–944, 2008. View at Publisher · View at Google Scholar · View at PubMed